Valter Viana Andrade-Neto

Dr. Valter Viana Andrade-Neto

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2016 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
TPThaís Martins Pereira
Thaís Martins Pereira
MCMarilene Do Canto-Cavalheiro
Marilene Do Canto-Cavalheiro
ETEduardo Caio Torres-Santos
Eduardo Caio Torres-Santos
Imipramine, a tricyclic antidepressant widely used clinically, has other pharmacological effects, such as antileishmanial activity. Tricyclic antidepressants interact with lipid bilayers, and some studies have shown that imipramine inhibits methyltransferases. Leishmania spp. produces compounds with an ergostane skeleton instead of a cholesterol skeleton, and the inhibition of enzymes of the sterol biosynthesis pathway is an interesting therapeutic target. Among these enzymes, C-24 methyltransferase has been suggested to play an essential role, as its inhibition kills the parasites. In this context, we investigated whether imipramine alters the biosynthesis of sterols in L. amazonensis and evaluated the efficacy of imipramine alone and in combination with miconazole, a classical inhibitor of another step in this pathway. To analyze the interference of imipramine with sterol metabolism, promastigotes of L. amazonensis were cultured with medium alone, 15 or 30 μM imipramine or 4 μM miconazole, and their lipids were extracted with methanol/chloroform/water (1:0.5:0.4 v/v) and analyzed by GC/MS. To assess the antileishmanial activity of the treatments, promastigotes of L. amazonensis were incubated with various concentrations of imipramine up to 100 μM and up to 24 μM miconazole. Promastigotes were also treated with the combination of imipramine and miconazole at concentrations up to 12.5 μM of imipramine and 24 μM of miconazole. Parasite growth was evaluated by the MTT assay. The fractional inhibitory concentration index (FICI) was calculated to determine whether there were synergistic effects. Peritoneal macrophages with and without L. amazonensis infection were treated with miconazole (0 – 16 μM) or imipramine (0 to 50 μM) for 72 hours. For assays of the combined treatment in amastigotes, the concentration of imipramine was fixed at 12.5 μM and various concentrations of miconazole were used up to 16 μM. The infection rate was determined by counting the infected macrophages under a light microscope. Promastigotes treated with imipramine accumulated cholesta-5,7,22-trien-3β-ol and cholesta-7-24-dien- 3β-ol, sterols that normally increase after treatment with classical inhibitors of C-24 methyltransferase. The IC50 of miconazole in promastigotes decreased when it was used in combination with imipramine, resulting in an additive effect, with a FICI value of 0.83. Imipramine also showed activity against intracellular amastigotes and enhanced the activity of miconazole, without apparent toxicity to the host cells. Imipramine was confirmed to have antileishmanial activity in both forms of the parasite, affecting the sterol biosynthesis of the organisms. Using imipramine in combination with azoles may be advantageous for the treatment of leishmaniasis.

3 January 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
EJEdezio Ferreira da Cunha Junior
Edezio Ferreira da Cunha Junior
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
MLMarta Lopes Lima
Marta Lopes Lima
TCThais Alves da Costa-Silva
Thais Alves da Costa-Silva
Andres Jimenez Galisteo Jr.Andres Jimenez Galisteo Jr.
Andres Jimenez Galisteo Jr.
ETEduardo Caio Torres-Santos
Eduardo Caio Torres-Santos
The leishmanicidal action of tricyclic antidepressants has been studied and evidences have pointed that their action is linked to inhibition of trypanothione reductase, a key enzyme in the redox metabolism of pathogenic trypanosomes. Cyclobenzaprine (CBP) is a tricyclic structurally related to the antidepressant amitriptyline, differing only by the presence of a double bond in the central ring. This paper describes the effect of CBP in experimental visceral leishmaniasis, its inhibitory effect in trypanothione reductase and the potential immunomodulatory activity. In vitro antileishmanial activity was determined in promastigotes and in L. infantum-infected macrophages. For in vivo studies, L. infantum-infected BALB/c mice were treated with CBP by oral gavage for five days and the parasite load was estimated. Trypanothione reductase activity was assessed in the soluble fraction of promastigotes of L. infantum. For evaluation of cytokines, L. infantum-infected macrophages were co-cultured with BALB/c splenocytes and treated with CBP for 48 h. The supernatant was analyzed for IL-6, IL-10, MCP-1, IFN-γ and TNF-α. CBP demonstrated an IC50 of 14.5±1.1μM and an IC90 of 74.5±1.2 μM in promastigotes and an IC50 of 12.6±1.05 μM and an IC90 of 28.7±1.3 μM in intracellular amastigotes. CBP also reduced the parasite load in L. infantum-infected mice by 40.4±10.3% and 66.7±10.5% in spleen at 24.64 and 49.28 mg/kg, respectively and by 85.6±5.0 and 89.3±4.8% in liver at 24.64 and 49.28mg/kg, after a short-term treatment. CBP inhibited the trypanothione reductase activity with a Ki of 86 ± 7.7 μM and increased the ROS production in promastigotes. CBP inhibited in 53% the production of IL-6 in infected macrophages co-culture. To the best of our knowledge, this study is the first report of the in vivo antileishmanial activity of the FDA-approved drug CBP. Modulation of immune response and induction of oxidative stress in parasite seem to contribute to this efficacy. Leishmaniasis is the denomination of a worldwide widespread group of tropical neglected diseases caused by protozoa belonging to Leishmania genus. Several factors have competed to worsen its spreading, such as climate changes and the recent conflict in Syria. The visceral form is the most severe among them and it is fatal if untreated. There is no vaccine for humans and the therapeutic arsenal is quite limited. Drug repurposing is a strategy that aims to look for new uses for well stablished drugs. This approach has been pointed as an attractive option to fasten the development of new treatment for leishmaniasis. Here, the authors evaluated the activity of cyclobenzaprine (CBP), a classical muscle relaxant, in a murine model of visceral leishmaniasis and investigated mechanisms involved in its leishmanicidal action. CBP was effective in reducing the parasite burden both in cell culture and in the liver and spleen of Leishmania-infected mice. Furthermore, the experimental data suggested that CBP interferes in the redox balance of the parasite and modulates the immune response of the host. Altogether, these results encourage further studies to evaluate the therapeutic usage of cyclobenzaprine for leishmaniasis.

28 May 2018 in Parasitology
Verified
Journal Article
Open access
PDF file
KRKarina Mastropasqua Rebello
Karina Mastropasqua Rebello
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
AZAline A. Zuma
Aline A. Zuma
MMMaria Cristina Machado Motta Cristina Motta
Maria Cristina Machado Motta Cristina Motta
CGClaudia Regina B. Gomes
Claudia Regina B. Gomes
CDClaudia M d’Avila-Levy
Claudia M d’Avila-Levy
The anti-leishmania effects of HIV peptidase inhibitors (PIs) have been widely reported; however, the biochemical target and mode of action are still a matter of controversy inLeishmaniaparasites. Considering the possibility that HIV-PIs induce lipid accumulation inLeishmania amazonensis, we analysed the effects of lopinavir on the lipid metabolism ofL. amazonensispromastigotes. To this end, parasites were treated with lopinavir at different concentrations and analysed by fluorescence microscopy and spectrofluorimetry, using a fluorescent lipophilic marker. Then, the cellular ultrastructure of treated and control parasites was analysed by transmission electron microscopy (TEM), and the lipid composition was investigated by thin-layer chromatography (TLC). Finally, the sterol content was assayed by gas chromatography–mass spectrometry (GC/MS). TEM analysis revealed an increased number of lipid inclusions in lopinavir-treated cells, which was accompanied by an increase in the lipophilic content, in a dose-dependent manner. TLC and GC–MS analysis revealed a marked increase of cholesterol-esters and cholesterol. In conclusion, lopinavir-induced lipid accumulation and affected lipid composition inL. amazonensisin a concentration–response manner. These data contribute to a better understanding of the possible mechanisms of action of this HIV-PI inL. amazonensispromastigotes. The concerted action of lopinavir on this and other cellular processes, such as the direct inhibition of an aspartyl peptidase, may be responsible for the arrested development of the parasite.

1 April 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
LDLuíza Dantas-Pereira
Luíza Dantas-Pereira
EJEdezio Ferreira da Cunha Junior
Edezio Ferreira da Cunha Junior
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
JBJohn F. Bower
John F. Bower
GJGuilherme A.M. Jardim
Guilherme A.M. Jardim
Rubem Menna-BarretoRubem Menna-Barreto
Rubem Menna-Barreto
Chagas disease, Sleeping sickness and Leishmaniasis, caused by trypanosomatids Trypanosoma cruzi, Trypanosoma brucei and Leishmania spp., respectively, are considered neglected tropical diseases, and they especially affect impoverished populations in the developing world. The available chemotherapies are very limited, and a search for alternatives is still necessary. In folk medicine, natural naphthoquinones have been employed for the treatment of a great variety of illnesses, including parasitic infections. This review is focused on the anti-trypanosomatid activity and mechanistic analysis of naphthoquinones and derivatives. Among all the series of derivatives tested in vitro, naphthoquinone-derived 1,2,3-triazoles were very active on T. cruzi infective forms in blood bank conditions, as well as in amastigotes of Leishmania spp. naphthoquinones containing a CF3 on a phenyl amine ring inhibited T. brucei proliferation in the nanomolar range, and naphthopterocarpanquinones stood out for their activity on a range of Leishmania species. Some of these compounds showed a promising selectivity index (SI) (30 to 1900), supporting further analysis in animal models. Indeed, high toxicity to the host and inactivation by blood components are crucial obstacles to be overcome to use naphthoquinones and/or their derivatives for chemotherapy. Multidisciplinary initiatives embracing medicinal chemistry, bioinformatics, biochemistry, and molecular and cellular biology need to be encouraged to allow the optimization of these compounds. Large scale automated tests are pivotal for the efficiency of the screening step, and subsequent evaluation of both the mechanism of action in vitro and pharmacokinetics in vivo is essential for the development of a novel, specific and safe derivative, minimizing adverse effects.

16 June 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
MRMayra M. Reimann
Mayra M. Reimann
ETEduardo Caio Torres-Santos
Eduardo Caio Torres-Santos
CSCeleste S. F. de Souza
Celeste S. F. de Souza
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
Ana Maria JansenAna Maria Jansen
Ana Maria Jansen
André Luiz Rodrigues RoqueAndré Luiz Rodrigues Roque
André Luiz Rodrigues Roque
Although Leishmania transmission in nature is associated with the bite of an infected sandfly vector, other possible transmission routes are speculated to occur, such as the oral route. We evaluated the possibility of infection by this route in golden hamsters (Mesocricetus auratus) using Leishmania braziliensis (Lb) and Leishmania infantum (Li). Hamsters were exposed to experimental oral or intragastrical infection with axenic promastigotes, besides oral ingestion of a suspension of cultivated macrophages infected with amastigotes, lesion-fed Lutzomyia longipalpis, skin lesion or infective spleen fragment. The parasite’s isolation, besides a positive PCR and IFAT, confirmed the intragastric infection by promastigote parasites. The oral ingestion of macrophages infected with L. braziliensis amastigotes was also infective. These results confirmed that Leishmania parasites could infect mammals by the intragastric route through the ingestion of promastigote forms (what can happen after a sandfly ingestion) and by the oral ingestion of infected macrophages (what can happen in nature in a predator–prey interaction). The better understanding of these alternative routes is essential to understand their transmission dynamics in nature. As far as we know, this is the first time that oral and intragastric Leishmania transmission has been experimentally demonstrated, constituting new infection routes, at least for L. infantum and L. braziliensis.

Verified
Journal Article
Open access
PDF file
PGPollyanna Stephanie Gomes
Pollyanna Stephanie Gomes
MCMonique Pacheco Duarte Carneiro
Monique Pacheco Duarte Carneiro
PMPatrícia de Almeida Machado
Patrícia de Almeida Machado
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
AMALESSANDRA MARCIA da FONSECA MARTINS
ALESSANDRA MARCIA da FONSECA MARTINS
HGHerbert L. de Matos Guedes
Herbert L. de Matos Guedes
Subtilisin proteases, found in all organisms, are enzymes important in the post-translational steps of protein processing. In Leishmania major and L. donovani, this enzyme has been described as essential to their survival; however, few compounds that target subtilisin have been investigated for their potential as an antileishmanial drug. In this study, we first show, by electron microscopy and flow cytometry, that subtilisin has broad localization throughout the cytoplasm and membrane of the parasite in the promastigote form with foci in the flagellar pocket. Through in silico analysis, the similarity between subtilisin of different Leishmania species and that of humans were determined, and based on molecular docking, we evaluated the interaction capacity of a serine protease inhibitor against both life cycle forms of Leishmania. The selected inhibitor, known as PF-429242, has already been used against the dengue virus, arenaviruses, and the hepatitis C virus. Moreover, it proved to have antilipogenic activity in a mouse model and caused hypolipidemia in human cells in vitro. Here, PF-429242 significantly inhibited the growth of L. amazonensis promastigotes of four different strains (IC50 values = 3.07 ± 0.20; 0.83 ± 0.12; 2.02 ± 0.27 and 5.83 ± 1.2 µM against LTB0016, PH8, Josefa and LV78 strains) whilst having low toxicity in the host macrophages (CC50 = 170.30 µM). We detected by flow cytometry that there is a greater expression of subtilisin in the amastigote form; however, PF-429242 had a low effect against this intracellular form with an IC50 of >100 µM for intracellular amastigotes, as well as against axenic amastigotes (94.12 ± 2.8 µM for the LV78 strain). In conclusion, even though PF-429242 does not affect the intracellular forms, this drug will serve as a tool to explore pharmacological and potentially leishmanicidal targets.